CTI BioPharma Corp. News
What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
TheStreet's biotech columnist offers his own report card on biotech stocks.
2016 was a terrible year for biotech but the tweets were on point
A look back at the year's worth of Adam Feuerstein's biotech tweets.
Gilead Sciences' next challenge to Incyte's myelofibrosis drug dominance
Gilead Sciences is nearing the completion of two phase III studies of the Jak inhibitor momelotinib in myelofibrosis, a disease affecting bone marrow.
Insider Trading Alert - LPNT, PATK And CTIC Traded By Insiders
Stocks with insider trader activity include LPNT, PATK and CTIC
Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders
Stocks with insider trader activity include SPTN, FL and CTIC
Insider Trading Alert - ATRS, CMT And CTIC Traded By Insiders
Stocks with insider trader activity include ATRS, CMT and CTIC
Insider Trading Alert - DRE And CTIC Traded By Insiders
Stocks with insider trader activity include DRE, CTIC and WAFD
Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold for Himself
In the latest blowup, excess patient deaths forced CTI Bio to yank a new drug application for the myelofibrosis drug pacritinib.
These under-$10 biotech stocks are about to trigger big breakout trades.
These biotech stocks trading for less than $10 a share are within range of triggering breakout trades.
The Arena Group Q2 Gross Profit Nearly Doubles; Revenue Up 87%
The Arena Group, publisher of Sports Illustrated, TheStreet, Parade and more, reported that Q2 gross profit, revenue and digital-ad revenue jumped.
Will JetBlue Take Away the One Thing People Like About Spirit?
The takeover of the budget airline raises a key question for consumers.
Micron and Nvidia: Buy or Sell After Bearish Updates?
Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.